Robert Stuart to Precursor Cell Lymphoblastic Leukemia-Lymphoma
This is a "connection" page, showing publications Robert Stuart has written about Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Connection Strength
0.273
-
A phase I clinical-pharmacodynamic study of the farnesyltransferase inhibitor tipifarnib in combination with the proteasome inhibitor bortezomib in advanced acute leukemias. Clin Cancer Res. 2011 Mar 01; 17(5):1140-6.
Score: 0.090
-
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia. Br J Haematol. 2010 Dec; 151(5):430-4.
Score: 0.089
-
Jumping translocation of 1q in BCR/ABL-positive acute lymphoblastic leukemia. Cancer Genet Cytogenet. 2007 Jan 01; 172(1):90-1.
Score: 0.068
-
Autologous bone marrow transplantation for leukemia. Semin Oncol. 1993 Oct; 20(5 Suppl 6):40-54.
Score: 0.027